HEMOGLOBINOPATHIES
Clinical trials for HEMOGLOBINOPATHIES explained in plain language.
Never miss a new study
Get alerted when new HEMOGLOBINOPATHIES trials appear
Sign up with your email to follow new studies for HEMOGLOBINOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant technique aims to cut deadly side effect in Half-Matched donors
Disease control OngoingThis study tests a way to make stem cell transplants safer for people with blood cancers or immune disorders who don't have a fully matched donor. By removing certain immune cells from the donated cells, doctors hope to lower the risk of graft-versus-host disease, a serious compl…
Matched conditions: HEMOGLOBINOPATHIES
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New Half-Matched transplant offers hope for sickle cell patients
Disease control OngoingThis early-phase study tests a new type of stem cell transplant for people with severe sickle cell disease who don't have a fully matched donor. It uses a half-matched relative's stem cells, a gentle chemotherapy prep, and removes certain immune cells to reduce side effects. The …
Matched conditions: HEMOGLOBINOPATHIES
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC